Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity.
about
The role of NKT cells in tumor immunityAutoimmune disease triggered by infection with alphaproteobacteriaSustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer.Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agentsDoes an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?Antitumor Responses of Invariant Natural Killer T CellsThe Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell GenerationImaging of NKT Cell Recirculation and Tissue Migration during Antimicrobial ImmunityThe regulatory role of invariant NKT cells in tumor immunityThe immunoregulatory role of type I and type II NKT cells in cancer and other diseasesA glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primatesMAIT cells: new guardians of the liverAlpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramideReciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.Development of a qPCR method to rapidly assess the function of NKT cells.Fatty acid amide hydrolase shapes NKT cell responses by influencing the serum transport of lipid antigen in mice.Spleen-resident CD4+ and CD4- CD8α- dendritic cell subsets differ in their ability to prime invariant natural killer T lymphocytes.Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy.NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and InflammationNKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge.Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccinationCombination of intratumoral invariant natural killer T cells and interferon-gamma is associated with prognosis of hepatocellular carcinoma after curative resection.Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects.Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours.The split personality of NKT cells in malignancy, autoimmune and allergic disordersNatural killer T cells as targets for immunotherapy of autoimmune diseases.IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2.Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastomaGoing both ways: immune regulation via CD1d-dependent NKT cells.Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity.alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.Contact-dependent interference with invariant NKT cell activation by herpes simplex virus-infected cells.Invariant Natural Killer T Cell Deficiency and Functional Impairment in Sleep Apnea: Links to Cancer ComorbidityAlpha-lactosylceramide as a novel "sugar-capped" CD1d ligand for natural killer T cells: biased cytokine profile and therapeutic activities.Dendritic cells in atherosclerosis: current status of the problem and clinical relevance.Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity.
P2860
Q24648939-8B72813D-6265-4CDF-AC15-2C6A3B8800E1Q24655779-83989464-A283-470A-AEB0-E0B9C55FB2B9Q25255724-876A679C-E04A-4829-BABF-37CB0050B76FQ25256900-ED694120-17DA-4331-B247-05338172CE25Q26748456-F43272AC-A667-4A5E-A01F-35AD0744C96CQ26768699-0B44680A-566F-4C05-8A84-8D77CEA70B0BQ26778648-95C38C61-8D33-48A4-AE3D-39F51234C782Q26797344-7761C6FD-C15B-468C-979B-4F884E821B9DQ26799999-31066F7E-500A-4EC4-8321-A3BCCF477365Q27023425-55F5D68D-82E2-4AF3-89B7-8D8BC0075903Q27027556-2CEF7622-423D-4B1E-810E-9C2F7B2D7CEEQ27303293-4A623C0C-C4DB-4446-89D0-9241A5E2D238Q28073095-BA213624-5131-40EA-A781-72B67CF87859Q30377447-3775AD28-733B-4B66-B73A-70E4DEE621FEQ33389529-8C510C09-529B-4596-A75C-06A8A321EC9DQ33720359-D1EDD7F3-C00C-49E9-A67F-5E3A26304091Q33733648-2DAF6ED2-A22E-4A60-A5A8-A03186549568Q33815383-491CF4CB-EDE3-4E56-A83E-B7E690BCDCCFQ33882880-FAF8513C-F395-4F11-A3A2-7797F350A35FQ34069630-570B04C4-2CB5-44AC-8E1A-4DD6286219F7Q34275397-865AC7FF-076B-4046-983F-D8AADEADE236Q34288977-DCD89AA2-CCE6-425C-B259-251805642DA1Q34333607-9516E7BE-DF56-44DB-96FE-2CB5D394B41CQ34517948-F3FC1001-D0C9-4298-9C99-799E4B123975Q34934974-1621D9A0-CC43-4578-A1C5-1D7B4D17B709Q35127172-5CD0400E-485D-42D1-B675-8BBB903F6FCDQ35208161-66771256-92AA-46E4-A0CD-9B66AB41BA9BQ35590727-115FA03C-5282-458E-8CB9-C47D8BAF0E57Q35798168-F5649CD1-2209-42B2-AA5B-DDBB7F925217Q35847866-D87E5F49-64C7-4B28-BD4A-CC3DE3E2BDE9Q35925629-178C5C21-5BE5-4DC2-90A3-CED99A1A0BB9Q35951531-2EB88E8E-D9DF-4D3F-8DD5-93473FE8C565Q35973205-480D6014-059A-472C-B873-01427B067482Q35990678-A2F40311-38D9-4374-8F01-B6B0482F8886Q35998799-C38B57BA-A121-4DE7-AD76-F8EE47D0C7AAQ36016560-78123D6B-5EFD-4EEE-BA96-948BCD10BA5FQ36076707-5642ED8E-5F3F-4A0C-A0A6-4B2A6D73C56EQ36099369-4EC7AA86-FCD7-4260-B837-6596FCAD5BEFQ36108241-FCFEC047-D592-43A1-96C3-97F228A469CCQ36199422-8B1F0295-2148-4942-89A3-630966AF52EC
P2860
Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Therapeutic activation of Valp ...... acquired and innate immunity.
@en
Therapeutic activation of Valp ...... acquired and innate immunity.
@nl
type
label
Therapeutic activation of Valp ...... acquired and innate immunity.
@en
Therapeutic activation of Valp ...... acquired and innate immunity.
@nl
prefLabel
Therapeutic activation of Valp ...... acquired and innate immunity.
@en
Therapeutic activation of Valp ...... acquired and innate immunity.
@nl
P2093
P1433
P1476
Therapeutic activation of Valp ...... acquired and innate immunity.
@en
P2093
Andrea Tazbirkova
Andrew J Nicol
Ayako Yamaura
David J Macfarlane
Kazuki Ide
Rick Abraham
Takeo Juji
P304
P356
10.1182/BLOOD-2003-04-1155
P407
P577
2003-09-25T00:00:00Z